MUC1 Vaccine for Triple-negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Inflammatory Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Triple-negative Breast Cancer
Interventions: BIOLOGICAL: MUC-1 peptide vaccine|BIOLOGICAL: poly ICLC|BIOLOGICAL: MUC1 peptide-poly-ICLC adjuvant vaccine|OTHER: laboratory biomarker analysis|OTHER: enzyme-linked immunosorbent assay|OTHER: flow cytometry
Sponsor: Joseph Baar, MD, PhD